Two Sigma Advisers
KRON

Two Sigma Advisers’s Kronos Bio KRON Stock Holding History

Two Sigma Advisers’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-175,400
Closed -$175K – 2443
2024
Q3 		$175K Sell
175,400
-19,000
-10% -$21K ﹤0.01% 2102
2024
Q2 		$241K Sell
194,400
-17,400
-8% -$17.7K ﹤0.01% 2152
2024
Q1 		$275K Sell
211,800
-2,900
-1% -$3.31K ﹤0.01% 2100
2023
Q4 		$268K Sell
214,700
-28,800
-12% -$31.9K ﹤0.01% 2139
2023
Q3 		$317K Sell
243,500
-91,400
-27% -$148K ﹤0.01% 1963
2023
Q2 		$576K Buy
334,900
+86,700
+35% +$138K ﹤0.01% 1763
2023
Q1 		$362K Sell
248,200
-6,400
-3% -$12.3K ﹤0.01% 2071
2022
Q4 		$412K Sell
254,600
-5,900
-2% -$13.6K ﹤0.01% 1953
2022
Q3 		$873K Buy
260,500
+62,200
+31% +$281K ﹤0.01% 1588
2022
Q2 		$722K Buy
198,300
+184,800
+1,369% +$838K ﹤0.01% 1756
2022
Q1 		$98K Sell
13,500
-7,600
-36% -$64.8K ﹤0.01% 2509
2021
Q4 		$287K Buy
+21,100
New +$330K ﹤0.01% 2157

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers's KRON Position: Q4 2024 in Review

Two Sigma Advisers sold out of Kronos Bio (KRON) in Q4 2024, closing a stake of 175,400 shares — an estimated $175K sold.

Two Sigma Advisers first reported a position in KRON in Q4 2021 and held it in 12 quarters. The position peaked at $873K in Q3 2022. 56 funds tracked by Wall St. Rank hold KRON as of Q4 2024.

  • Two Sigma Advisers reported no remaining Kronos Bio position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 175,400 Kronos Bio shares in Q4 2024, an estimated $175K.
  • Two Sigma Advisers first reported a position in Kronos Bio in Q4 2021 and held it in 12 quarters.
  • Two Sigma Advisers's Kronos Bio position peaked at $873K in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2024.

Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.